DeutschNewstral
Article
The Hindu on 2021-12-01 18:22
More data on Covaxin jabs for children sought
Related news
- Covaxin for children: recommendations being studied, says MinisterThe Hindu
- Covaxin does not have WHO’s emergency use listing for use in childrenThe Hindu
- Coronavirus updates | Covaxin nod: WHO seeks more dataThe Hindu
- Corbevax, Covaxin get drug regulator nod for use in childrenThe Hindu
- Updated data from Covaxin phase 3 trial shows 78% efficacyThe Hindu
- Coronavirus | More antibodies produced after Covishield than Covaxin, says studyThe Hindu
- Covishield produces more anti-bodies than Covaxin, says studyThe Hindu
- Govt for scientific decision on booster dose, jabs for childrenThe Hindu
- Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat BiotechThe Hindu
- Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacyThe Hindu
- COVID-19 | AIIMS Delhi starts screening of children for Covaxin trialsThe Hindu
- Covaxin data given to WHO for nodThe Hindu
- Review of Covaxin underway, says WHOThe Hindu
- WHO grants Covaxin ‘Emergency Use Listing’The Hindu
Coronavirus: Malaysia to lift more curbs, eases mask mandate; India’s Modi urges jabs for childrenSouth China Morning Post- Coronavirus live updates | Covaxin to be administered in 7 more StatesThe Hindu
- Covaxin development has proved India is more than pharmacy of world: ICMR chiefThe Hindu
- COVID-19 | Govt. to wait for expert view on booster dose, jabs for childrenThe Hindu
Covaxin phase 3 data shows 77.8% efficacy: LancetThe Times of India- Expert panel approves Covaxin for children between 2-18 yearsThe Times of India